RPRX logo

Royalty Pharma plc (RPRX) Cash From Financing

Annual CFF:

$356.04M+$2.52B(+116.47%)
December 31, 2024

Summary

  • As of today, RPRX annual cash from financing is $356.04 million, with the most recent change of +$2.52 billion (+116.47%) on December 31, 2024.
  • During the last 3 years, RPRX annual cash from financing has risen by +$15.14 million (+4.44%).
  • RPRX annual cash from financing is now -74.92% below its all-time high of $1.42 billion, reached on December 31, 2020.

Performance

1-Year Change

+116.47%

3-Year Change

+4.44%

5-Year Change

+129.88%

15-Year Change

+388.87%

RPRX Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

94.74%
RPRX annual cash from financing is higher than 94.74% of companies in Healthcare sector

Range

All-Time High

$1.42B
RPRX annual cash from financing is currently -74.92% below its historical high of $1.42 billion

3-Year Low

-$2.16B
RPRX annual cash from financing is currently +116.47% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
RPRX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
RPRX next annual earnings announcement has not yet been scheduled

OtherRPRXcash flow metrics

Annual CFI

-$2.70B
RPRX annual cash from investing is -$2.70 billion

Annual CFO

$2.79B
RPRX annual cash from operations is $2.79 billion

Annual FCF

$268.93M
RPRX annual free cash flow is $268.93 million

Annual CAPEX

$2.52B
RPRX annual capital expenditures is $2.52 billion

Quarterly CFF:

-$507.81M+$433.49M(+46.05%)
June 30, 2025

Summary

  • As of today, RPRX quarterly cash from financing is -$507.81 million, with the most recent change of +$433.49 million (+46.05%) on June 30, 2025.
  • Over the past year, RPRX quarterly cash from financing has dropped by -$1.66 billion (-143.91%).
  • RPRX quarterly cash from financing is now -132.15% below its all-time high of $1.58 billion, reached on June 30, 2020.

Performance

3-Month Change

+46.05%

1-Year Change

-143.91%

3-Year Change

-122.48%

5-Year Change

-132.15%

RPRX Quarterly Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

2.58%
RPRX quarterly cash from financing is higher than 2.58% of companies in Healthcare sector

Range

All-Time High

$1.58B
RPRX quarterly cash from financing is currently -132.15% below its historical high of $1.58 billion

3-Year Low

-$1.36B
RPRX quarterly cash from financing is currently +62.65% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
RPRX previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 5, 2025
RPRX next earnings announcement is scheduled for Nov 5, 2025

OtherRPRXcash flow metrics

Quarterly CFI

-$311.98M
RPRX quarterly cash from investing is -$311.98 million

Quarterly CFO

$363.98M
RPRX quarterly cash from operations is $363.98 million

Quarterly FCF

$363.98M
RPRX quarterly free cash flow is $363.98 million

Quarterly CAPEX

$1.11M
RPRX quarterly capital expenditures is $1.11 million

TTM CFF:

-$2.03B-$1.66B(-452.10%)
June 30, 2025

Summary

  • As of today, RPRX TTM cash from financing is -$2.03 billion, with the most recent change of -$1.66 billion (-452.10%) on June 30, 2025.
  • Over the past year, RPRX TTM cash from financing has dropped by -$1.39 billion (-214.27%).
  • RPRX TTM cash from financing is now -230.67% below its all-time high of $1.56 billion, reached on June 30, 2020.

Performance

3-Month Change

-452.1%

1-Year Change

-214.27%

3-Year Change

-625.25%

5-Year Change

-237.45%

RPRX TTM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

2.76%
RPRX TTM cash from financing is higher than 2.76% of companies in Healthcare sector

Range

All-Time High

$1.56B
RPRX TTM cash from financing is currently -230.67% below its historical high of $1.56 billion

3-Year Low

-$2.18B
RPRX TTM cash from financing is currently +6.87% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2025
RPRX previous earnings announcement was published on Jun 30, 2025

Next Quarterly Earnings Report Date

Nov 5, 2025
RPRX next earnings announcement is scheduled for Nov 5, 2025

OtherRPRXcash flow metrics

TTM CFI

-$1.51B
RPRX TTM cash from investing is -$1.51 billion

TTM CFO

$2.41B
RPRX TTM cash from operations is $2.41 billion

TTM FCF

$2.41B
RPRX TTM free cash flow is $2.41 billion

TTM CAPEX

$1.69B
RPRX TTM capital expenditures is $1.69 billion

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

RPRX Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+116.5%-143.9%-214.3%
3Y3 Years+4.4%-122.5%-625.3%
5Y5 Years+129.9%-132.2%-237.4%

RPRX Cash From Financing Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+116.5%-143.9%+62.6%-624.9%+6.9%
5Y5-Year-74.9%+116.5%-143.9%+62.6%-236.7%+6.9%
All-TimeAll-Time-74.9%+116.5%-132.2%+62.6%-230.7%+6.9%

RPRX Cash From Financing History

DateAnnualQuarterlyTTM
Jun 2025
-
-$507.81M(+46.1%)
-$2.03B(-452.1%)
Mar 2025
-
-$941.30M(-264.9%)
-$368.16M(-201.9%)
Dec 2024
$356.04M(+116.5%)
-$257.96M(+20.7%)
$361.14M(-6.7%)
Sep 2024
-
-$325.50M(-128.1%)
$387.21M(+159.9%)
Jun 2024
-
$1.16B(+645.6%)
-$646.77M(+69.9%)
Mar 2024
-
-$212.00M(+8.6%)
-$2.15B(-0.1%)
Dec 2023
-$2.16B(-127.0%)
-$231.89M(+82.9%)
-$2.15B(+1.5%)
Sep 2023
-
-$1.36B(-291.8%)
-$2.18B(-107.3%)
Jun 2023
-
-$347.00M(-64.9%)
-$1.05B(-12.7%)
Mar 2023
-
-$210.37M(+20.8%)
-$934.26M(+1.1%)
Dec 2022
-$952.05M(-379.3%)
-$265.55M(-15.4%)
-$944.86M(-7.7%)
Sep 2022
-
-$230.09M(-0.8%)
-$877.38M(-326.7%)
Jun 2022
-
-$228.25M(-3.3%)
$386.98M(-1.0%)
Mar 2022
-
-$220.97M(-11.6%)
$390.82M(+1.5%)
Dec 2021
$340.90M
-$198.07M(-119.2%)
$385.11M(+25.9%)
DateAnnualQuarterlyTTM
Sep 2021
-
$1.03B(+560.9%)
$305.79M(+128.2%)
Jun 2021
-
-$224.41M(+1.0%)
-$1.09B(-251.2%)
Mar 2021
-
-$226.67M(+18.3%)
$717.98M(-51.7%)
Dec 2020
$1.42B(+219.1%)
-$277.39M(+22.4%)
$1.49B(+0.6%)
Sep 2020
-
-$357.39M(-122.6%)
$1.48B(-4.9%)
Jun 2020
-
$1.58B(+191.1%)
$1.56B(+565.5%)
Mar 2020
-
$542.52M(+289.8%)
-$334.15M(+72.0%)
Dec 2019
-$1.19B(+13.6%)
-$285.80M(-1.8%)
-$1.19B(-31.6%)
Sep 2019
-
-$280.69M(+9.5%)
-$905.82M(-44.9%)
Jun 2019
-
-$310.18M(+1.5%)
-$625.13M(-98.5%)
Mar 2019
-
-$314.96M
-$314.96M
Dec 2018
-$1.38B(-1018.9%)
-
-
Dec 2017
-$123.25M(+86.7%)
-
-
Dec 2016
-$923.32M(>-9900.0%)
-
-
Dec 2015
-$6.75M
-
-

FAQ

  • What is Royalty Pharma plc annual cash from financing?
  • What is the all-time high annual cash from financing for Royalty Pharma plc?
  • What is Royalty Pharma plc annual cash from financing year-on-year change?
  • What is Royalty Pharma plc quarterly cash from financing?
  • What is the all-time high quarterly cash from financing for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly cash from financing year-on-year change?
  • What is Royalty Pharma plc TTM cash from financing?
  • What is the all-time high TTM cash from financing for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM cash from financing year-on-year change?

What is Royalty Pharma plc annual cash from financing?

The current annual cash from financing of RPRX is $356.04M

What is the all-time high annual cash from financing for Royalty Pharma plc?

Royalty Pharma plc all-time high annual cash from financing is $1.42B

What is Royalty Pharma plc annual cash from financing year-on-year change?

Over the past year, RPRX annual cash from financing has changed by +$2.52B (+116.47%)

What is Royalty Pharma plc quarterly cash from financing?

The current quarterly cash from financing of RPRX is -$507.81M

What is the all-time high quarterly cash from financing for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly cash from financing is $1.58B

What is Royalty Pharma plc quarterly cash from financing year-on-year change?

Over the past year, RPRX quarterly cash from financing has changed by -$1.66B (-143.91%)

What is Royalty Pharma plc TTM cash from financing?

The current TTM cash from financing of RPRX is -$2.03B

What is the all-time high TTM cash from financing for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM cash from financing is $1.56B

What is Royalty Pharma plc TTM cash from financing year-on-year change?

Over the past year, RPRX TTM cash from financing has changed by -$1.39B (-214.27%)
On this page